4//SEC Filing
Herman James L 4
Accession 0001209191-22-026142
CIK 0001087294other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 1:04 PM ET
Size
7.1 KB
Accession
0001209191-22-026142
Insider Transaction Report
Form 4
Herman James L
See Remarks
Transactions
- Award
Options (right to buy)
2022-03-16+6,000→ 6,000 totalExercise: $2.59From: 2026-03-16Exp: 2032-03-16→ Common Stock (6,000 underlying) - Tax Payment
Common Stock
2022-03-20$2.74/sh−1,280$3,507→ 40,721 total
Footnotes (2)
- [F1]This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
- [F2]100% vesting on March 16, 2026.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001572342
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 1:04 PM ET
- Size
- 7.1 KB